Clinical Trials

Clinical Trials: Nephrology

W. Kline Bolton, PI:

• Study to Evaluate the Long-Term Efficacy & Safety of Oral Tolvaptan Tablet, Protocol 156-08-271
• A Three-period, 58-week safety and efficacy trial of KRX-0502 (ferric citrate) in patients with end-stage renal disease on dialysis, KRX-0502
• Celgene Renal Anemia Study, ACE-011-REN-001
• A Long-Term Safety Extension Trial of KRX-0502 in Patients with End-Stage Renal Disease on Dialysis, KRX-0502

Charles H. Brooks, PI:

• A randomized, multicenter, double-blind, placebo controlled study of AC607 for the treatment of acute kidney injury in cardiac surgery subjects (Phase 2), AC6071103

Mitchell Rosner, PI:

• MD-INMD Covance, Inc. – Tolvaptan PKD-156-09-290, 156-09-29.